Your browser doesn't support javascript.
loading
Comparative Safety of Sodium-Glucose Cotransporter 2 Inhibitors Versus Dipeptidyl Peptidase 4 Inhibitors and Sulfonylureas on the Risk of Diabetic Ketoacidosis.
Dawwas, Ghadeer K; Flory, James H; Hennessy, Sean; Leonard, Charles E; Lewis, James D.
Afiliación
  • Dawwas GK; Center for Pharmacoepidemiology Research and Training, Center for Clinical Epidemiology and Biostatistics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA.
  • Flory JH; Department of Biostatistics, Epidemiology and Informatics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA.
  • Hennessy S; Leonard Davis Institute of Health Economics, University of Pennsylvania, Philadelphia, PA.
  • Leonard CE; Center for Pharmacoepidemiology Research and Training, Center for Clinical Epidemiology and Biostatistics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA.
  • Lewis JD; Endocrinology Service, Department of Subspecialty Medicine, Memorial Sloan Kettering Cancer Center, New York, NY.
Diabetes Care ; 45(4): 919-927, 2022 04 01.
Article en En | MEDLINE | ID: mdl-35147696

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Cetoacidosis Diabética / Diabetes Mellitus Tipo 2 / Inhibidores de la Dipeptidil-Peptidasa IV / Inhibidores del Cotransportador de Sodio-Glucosa 2 Tipo de estudio: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Diabetes Care Año: 2022 Tipo del documento: Article

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Cetoacidosis Diabética / Diabetes Mellitus Tipo 2 / Inhibidores de la Dipeptidil-Peptidasa IV / Inhibidores del Cotransportador de Sodio-Glucosa 2 Tipo de estudio: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Diabetes Care Año: 2022 Tipo del documento: Article